Northern Trust’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.7K Hold
33,572
﹤0.01% 4229
2025
Q4
$59.8K Hold
33,572
﹤0.01% 4243
2025
Q3
$80.9K Sell
33,572
-11,748
-26% -$28.5K ﹤0.01% 4184
2025
Q2
$103K Buy
45,320
+431
+1% +$1.07K ﹤0.01% 4104
2025
Q1
$121K Sell
44,889
-3,133
-7% -$8.87K ﹤0.01% 4070
2024
Q4
$126K Buy
48,022
+24,452
+104% +$65.8K ﹤0.01% 4113
2024
Q3
$63.2K Sell
23,570
-662
-3% -$1.81K ﹤0.01% 4163
2024
Q2
$60.5K Sell
24,232
-958
-4% -$2.24K ﹤0.01% 4176
2024
Q1
$59.7K Sell
25,190
-3,248
-11% -$8.76K ﹤0.01% 4194
2023
Q4
$79.9K Buy
+28,438
New +$81.9K ﹤0.01% 4155
2015
Q4
Hold
0
-$4K 4303
2015
Q3
Hold
0
4256
2015
Q2
Hold
0
4187
2015
Q1
Hold
0
4265
2014
Q4
Hold
0
4170
2014
Q3
Hold
0
4108
2014
Q2
Hold
0
4036
2014
Q1
Hold
0
3968

Other funds holding NSPR

Northern Trust's NSPR Position: Q1 2026 in Review

Northern Trust held its InspireMD (NSPR) position steady in Q1 2026 at 33,572 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4229.

Northern Trust first reported a position in NSPR in Q4 2023 and has held it in 10 quarters since. The position peaked at $126K in Q4 2024. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Northern Trust held 33,572 shares of InspireMD worth $54.7K as of Q1 2026.
  • Northern Trust left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4229 holding.
  • Northern Trust first reported a position in InspireMD in Q4 2023 and has held it in 10 quarters since.
  • Northern Trust's InspireMD position peaked at $126K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.